InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: goldenisla post# 28804

Sunday, 09/16/2018 8:10:52 PM

Sunday, September 16, 2018 8:10:52 PM

Post# of 232774
Gold - My take -

1.we will see few more raises before end of 2019 - they are increasing the activity and will need money.

2. Listen to Dr Pestell Utube video on CCR5 and cancer. He has invested his life in the theory that cancer cells in many cancers have CCR5 receptors pronounced and help them guide to other places leading to metastasis and if he can find right antagonist to bind CCR5 it will stop metastasis.
The only CCR5 antagonist approved is Marav from Pfizer and he does not think it is that effective.

Pro-140 is very safe and has shown efficacy and he clearly thinks that it will be effective.

Now think - if CYDY goes to $1 which is possibility by next year - he will worth $27 million - @ $2 he is worth $54 million.
Even if he goes to Pfizer, he will not get CMO post and will not get that kind of money and freedom.

So for him it is a win to get good money and opportunity to prove his theory and bring and effective treatment to market.

I am more excited about his enthusiasm and possibility of CYDY becoming a cancer play than HIV play - that will just keep on going.

I am also happy that 700 mg dose is in play - the no of cancer cell doing metastasis are much lower than HIV cell - cancer patients will be happy to take this non-toxic dose even twice a week. At that level, the binding concentration will be very high and it can control metastasis very effectively. This can be seen in secondary measure in very few weeks - so establishing the secondary efficacy will be much easier and it can get market much excited.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News